Selective depletion of dopamine following O-methylation of 6-hydroxydopamine
Ho, B.T.; Meyer, A.L.; Taylor, D.
Research Communications in Chemical Pathology and Pharmacology 6(1): 47-56
1973
ISSN/ISBN: 0034-5164 PMID: 4734016 Document Number: 59204
Document emailed within 1 workday
Related Documents
O'Donnell, J.M.; Seiden, L.S. 1984: Altered effects of desipramine on operant performance after 6-hydroxydopamine-induced depletion of brain dopamine or norepinephrine Journal of Pharmacology and Experimental Therapeutics 229(3): 629-635Breese, G.R.; Baumeister, A.A.; McCown, T.J.; Emerick, S.G.; Frye, G.D.; Crotty, K.; Mueller, R.A. 1984: Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: relevance to neurological symptoms in clinical syndromes with reduced brain dopamine Journal of Pharmacology and Experimental Therapeutics 231(2): 343-354
Molina-Holgado, E.; Dewar, K.M.; Descarries, L.; Reader, T.A. 1994: Altered dopamine and serotonin metabolism in the dopamine-denervated and serotonin-hyperinnervated neostriatum of adult rat after neonatal 6-hydroxydopamine Journal of Pharmacology and Experimental Therapeutics 270(2): 713-721
Wagner, G.C.; Ricaurte, G.A.; Johanson, C.E.; Schuster, C.R.; Seiden, L.S. 1980: Amphetamine induces depletion of dopamine and loss of dopamine uptake sites in caudate Neurology 30(5): 547-550
Morelli, A.; Narducci, F.; Camardella, G.; Pelli, M.A.; Floridi, A.; Nenci, G.G. 1977: Dopamine uptake by platelets in hepatic encephalopathy; evidence for a possible depletion of brain dopamine Acta Hepato-Gastroenterologica 24(6): 405-410
Kaplanski, J.; Smelik, P.G. 1973: Pituitary-adrenal activity and depletion of brain catecholamines after central administration of 6-hydroxydopamine Research Communications in Chemical Pathology and Pharmacology 5(2): 263-271
Pernevi, P.; Trolin, G. 1974: Lack of effect of protriptyline on the 6-hydroxydopamine-induced noradrenaline depletion in the rat spinal cord Journal of Pharmacy and Pharmacology 26(12): 978-979
Peterson, D.W.; Sparber, S.B. 1974: Increased fixed-ratio performance and differential d- and l-amphetamine action following norepinephrine depletion by intraventricular 6-hydroxydopamine Journal of Pharmacology and Experimental Therapeutics 191(3): 349-357
Decker, D.E.; Althaus, J.S.; Buxser, S.E.; VonVoigtlander, P.F.; Ruppel, P.L. 1993: Competitive irreversible inhibition of dopamine uptake by 6-hydroxydopamine Research Communications in Chemical Pathology and Pharmacology 79(2): 195-208
Asanuma, M.; Ogawa, N.; Nishibayashi, S.; Kawai, M.; Kondo, Y.; Iwata, E. 1995: Protective effects of pergolide on dopamine levels in the 6-hydroxydopamine-lesioned mouse brain Archives Internationales de Pharmacodynamie et de Therapie 329(2): 221-230
Ikegami, M.; Ichitani, Y.; Takahashi, T.; Iwasaki, T. 2006: Compensatory increase in extracellular dopamine in the nucleus accumbens of adult rats with neonatal 6-hydroxydopamine treatment Nihon Shinkei Seishin Yakurigaku Zasshi 26(3): 111-117
Criswell, H.; Mueller, R.A.; Breese, G.R. 1988: Assessment of purine-dopamine interactions in 6-hydroxydopamine-lesioned rats: evidence for pre- and postsynaptic influences by adenosine Journal of Pharmacology and Experimental Therapeutics 244(2): 493-500
Breese, G.R.; Baumeister, A.; Napier, T.C.; Frye, G.D.; Mueller, R.A. 1985: Evidence that D-1 dopamine receptors contribute to the supersensitive behavioral responses induced by L-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine Journal of Pharmacology and Experimental Therapeutics 235(2): 287-295
Graham, D.G.; Tiffany, S.M.; Bell, W.R.; Gutknecht, W.F. 1978: Autoxidation versus covalent binding of quinones as the mechanism of toxicity of dopamine, 6-hydroxydopamine, and related compounds toward C1300 neuroblastoma cells in vitro Molecular Pharmacology 14(4): 644-653
Agnoli, G.C.; Cacciari, M.; Garutti, C.; Lenzi, P. 1980: Sympathomimetic component of dopamine renal action in water-saline depletion Bollettino della Societa Italiana di Biologia Sperimentale 56(9): 939-945
Fuller, R.W.; Hemrick-Luecke, S.K. 1987: Persistent depletion of striatal dopamine and its metabolites in mice by TMMP, an analogue of MPTP Journal of Pharmacy and Pharmacology 39(8): 667-669
Karczmar, G.S.; Arbeit, J.M.; Toy, B.J.; Speder, A.; Weiner, M.W. 1992: Selective depletion of tumor ATP by 2-deoxyglucose and insulin, detected by 31P magnetic resonance spectroscopy Cancer Research 52(1): 71-76
Agnoli, G.C.; Borgatti, R.; Cacciari, M.; Garutti, C.; Ikonomu, E.; Lenzi, P.; Marinelli, M. 1990: Selective inhibitory effects of experimental potassium depletion on urinary excretion of prostanoids and their possible functional significance Bollettino della Societa Italiana di Biologia Sperimentale 66(9): 857-863
Soiffer, R.J.; Ritz, J. 1993: Selective T cell depletion of donor allogeneic marrow with anti-CD6 monoclonal antibody: rationale and results Bone Marrow Transplantation 12(Suppl 3): S7-10
Manca, F. 1992: Selective functional depletion of HIV gp120 peptides complexed with MHC from antigen-presenting cells engaged with specific T lymphocytes Journal of Immunology 149(3): 796-800